BIOLQ (Biolase) FCF Margin %: -41.22% (As of Sep. 2024)


BIOLQ Biolase Inc BIOLQ
16 GF Score
Price $0.00
View Full Analysis

What is Biolase FCF Margin %?

Biolase BIOLQ -99.00% 16 FCF Margin % is -41.22% as of Sep. 2024. GuruFocus rates BIOLQ with a GF Score™ of 16/100.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Biolase's Free Cash Flow for the three months ended in Sep. 2024 was $-4.47 Mil. Biolase's Revenue for the three months ended in Sep. 2024 was $10.85 Mil. Therefore, Biolase's FCF Margin % for the quarter that ended in Sep. 2024 was -41.22%.

As of today, Biolase's current FCF Yield % is 0.00%.

The historical rank and industry rank for Biolase's FCF Margin % or its related term are showing as below:

BIOLQ' s FCF Margin % Range Over the Past 10 Years
Min: -29.57   Med: 0   Max: 0
Current: -29.57

BIOLQ's FCF Margin % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -0.1 vs BIOLQ: -29.57

Biolase FCF Margin % Related Terms

Biolase FCF Margin % Historical Data

* Premium members only.

The historical data trend for Biolase's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolase FCF Margin % Chart

Biolase Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.27 -56.59 -44.44 -62.91 -31.33

Biolase Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.36 -18.30 -58.61 -6.35 -41.22

BIOLQ vs OPGN, AFIB, ABT: FCF Margin % Comparison

For the Medical Devices subindustry, Biolase's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biolase FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolase's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Biolase's FCF Margin % falls into.


BIOLQ
16GF Score
Biolase Inc BIOLQ
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biolase FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Biolase's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15.402/49.164
=-31.33 %

Biolase's FCF Margin for the quarter that ended in Sep. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-4.472/10.85
=-41.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -41.22% mean?
Biolase (BIOLQ) has a FCF Margin % of -41.22% as of Sep. 2024. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biolase and its competitors.
Is Biolase's FCF Margin % too high?
Biolase's current FCF Margin % is -41.22%. Overall, Biolase has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Biolase's FCF Margin % compare to OPGN and AFIB?
Biolase's FCF Margin % of -41.22% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Biolase and its competitors. Biolase's current FCF Margin % is -41.22%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biolase stock overvalued right now?
Biolase (BIOLQ) has a current FCF Margin % of -41.22%. The current FCF Margin % is -41.22%. Biolase's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Biolase (BIOLQ), the current FCF Margin % is -41.22% as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biolase Business Description

Address 27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610
Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
16GF Score

Get the complete analysis for BIOLQ

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price